CVE intelligence and bounded remediation

CVE-2018-18564 — Roche Accu-Chek Inform Ii Firmware security vulnerability

High CVSS 7.4

An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Serial Number above 14000), CoaguChek Pro II before 04.03.00, and cobas h 232 before 04.00.04 (Serial number above KQ0400000 or KS0400000). Improper access control allows attackers in the adjacent network to change the instrument configuration.

Severity
High
CVSS
7.4 (3.0)
Published
2018-11-20
CISA KEV
Not currently listed
Ecosystem
operating-system

Affected products

  • roche / accu-chek_inform_ii_firmware
  • roche / cobas_h_232_firmware
  • roche / coaguchek_pro_ii_firmware

Showing 3 representative product identities from 4 source matches. Confirm exact affected versions with the linked vendor and NVD evidence.

Matched remediation archetype

General vulnerability remediation

This catalog composition supplies bounded fallback guidance. Explicitly reviewed curated workflows load with the complete record below.

Check exposure

  • Confirm the affected component, deployment paths, reachable interfaces, and enabled features from inventories and configuration, without probing production destructively.
  • Compare the advisory's affected conditions with the repository lockfiles, build manifests, artifacts, and runtime inventory.
  • Identify data sensitivity, trust boundaries, and privilege level for every confirmed affected deployment.

Remediate safely

  • Apply a vendor-supported fix or remove the affected component or feature; record the selected change and its source in the repository.
  • Update direct and transitive dependency locks, generated artifacts, deployment manifests, and asset inventories together.
  • Add a regression test for the documented unsafe condition using inert inputs and preserve rollback instructions.

Authoritative sources

Complete CVE record and remediation plan

The detailed catalog view below loads this exact record, its source evidence, and the full seven-phase agentic change plan.